Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients (家族性內分泌癌症綜合症:兒童與青少年患者的護理轉換指南)
Hannah-Shmouni, Fady
- 出版商: Springer
- 出版日期: 2024-10-27
- 售價: $4,030
- 貴賓價: 9.5 折 $3,829
- 語言: 英文
- 頁數: 227
- 裝訂: Quality Paper - also called trade paper
- ISBN: 3031372778
- ISBN-13: 9783031372773
海外代購書籍(需單獨結帳)
相關主題
商品描述
This book is composed of 13 informative chapters written by world-renowned healthcare providers and researchers in the fields of endocrinology, pharmacy, radiology, infertility, pediatrics, internal medicine, psychology and genetics. From topics covering psychosocial impacts to pharmacokinetic and homecare resources, the intent of this book is to provide guiding principles for a safe and informative transition of care for pediatric and adolescent patients with various familial endocrine cancer syndromes that are transitioning from pediatric to adult health care. It provides an in-depth exploration of the diagnostic and therapeutic strategies, survivorship navigation intervention, patient, caregiver and primary care provider challenges, and multidisciplinary care plans for conditions such as MEN1, MEN2 and other familial and genetic endocrine neoplasias.
Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients is a much-needed resource, as the literature currently lacks a comprehensive publication to facilitate pediatric patients' transition to adult clinics and resources following endocrine cancer diagnosis and treatment.
商品描述(中文翻譯)
本書由全球知名的醫療提供者和研究人員撰寫,共包含13個資訊豐富的章節,涵蓋內分泌學、藥學、放射學、不孕症、兒科、內科、心理學和遺傳學等領域。書中主題從心理社會影響到藥物動力學及居家護理資源,旨在為患有各種家族性內分泌癌症綜合症的兒童和青少年患者提供安全且具資訊性的護理轉換指導原則,幫助他們從兒科轉至成人醫療。書中深入探討了診斷和治療策略、生存導航介入、患者、照顧者及初級醫療提供者所面臨的挑戰,以及針對MEN1、MEN2及其他家族性和遺傳性內分泌腫瘤的多學科護理計畫。
《Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients》是一本急需的資源,因為目前文獻中缺乏一部全面的出版物,以促進兒童患者在內分泌癌症診斷和治療後轉至成人診所和資源的過程。
作者簡介
Fady Hannah-Shmouni, MD ABIM FRCPC is a physician-entrepreneur specializing in internal medicine, neuroendocrinology and genetics, and early-stage investments and advisory in medtech, biotech, and blockchain companies. Dr. Shmouni completed clinical training in internal medicine at Yale School of Medicine; adult endocrinology, diabetes and metabolism at the National Institutes of Health, America's research hospital, under the mentorship of Constantine A. Stratakis; and clinical biochemical genetics at the University of Toronto. He is board-certified in internal medicine and endocrinology by the American Board of Internal Medicine and Royal College of Physician and Surgeons of Canada; and in clinical hypertension by the American Society of Hypertension.
During his tenure at NIH (2015-2021), Dr. Shmouni was the Director of Graduate Medical Education, Associate Program Director of the Inter-Institute Endocrinology Fellowship Program, and Primary Investigator on several genetic and adrenal related research protocols. His clinical and research focus was on the evaluation of patients with various inherited metabolic and endocrine conditions, including endocrine cancer predisposition syndromes, and was the Co-Chief of the outpatient endocrine clinic, where he oversaw the clinical management of patients with Carney complex, cushing syndrome, acromegaly, multiple endocrine neoplasia, and various inborn errors of metabolism.
Dr. Shmouni is a passionate clinician and advocate for rare diseases. He is a professor and staff physician at Vancouver General Hospital (University of British Columbia), practicing endocrinology and internal medicine. He is a fellow with the Royal College of Physicians and Surgeons of Canada and an active committee member of the Endocrine Society, International Society of Hypertension, Hypertension Canada Clinical Practice Guidelines, and is the Vice Chair of the Pituitary, Gonad, Adrenal and Neuroendocrine Resource Center of the AmericanAssociation of Clinical Endocrinology.
Dr. Shmouni is the Editor-In-Chief of Endocrine and Metabolic Science (Elsevier), and has authored or co-authored over 100 original articles, reviews and book chapters on neuroendocrine, genetic and metabolic conditions. Dr. Shmouni is enjoys entrepreneurship and early-stage venture work; he co-founded FHS Capital, specialising in early-stage startup consultations and investments, and helps early-stage founders with business strategy and fundraising.
作者簡介(中文翻譯)
Fady Hannah-Shmouni, MD ABIM FRCPC 是一位專注於內科、神經內分泌學和遺傳學的醫師企業家,並在醫療科技、生技和區塊鏈公司進行早期投資和顧問服務。Shmouni 博士在耶魯醫學院完成內科臨床訓練;在美國國立衛生研究院(NIH)接受成人內分泌學、糖尿病和代謝的訓練,並在 Constantine A. Stratakis 的指導下進行;以及在多倫多大學完成臨床生化遺傳學的訓練。他獲得美國內科醫學委員會和加拿大皇家內科醫師及外科醫師學院的內科和內分泌學專科認證;以及美國高血壓學會的臨床高血壓專科認證。
在 NIH 任職期間(2015-2021),Shmouni 博士擔任研究生醫學教育主任、跨機構內分泌學獎學金計畫的副計畫主任,以及多個與遺傳和腎上腺相關的研究計畫的主要研究者。他的臨床和研究重點是評估各種遺傳性代謝和內分泌疾病的患者,包括內分泌癌易感綜合症,並擔任門診內分泌診所的共同主任,負責管理患有 Carney 綜合症、庫欣症、肢端肥大症、多發性內分泌腫瘤及各種先天性代謝錯誤的患者的臨床事務。
Shmouni 博士是一位熱情的臨床醫師和罕見疾病的倡導者。他是溫哥華綜合醫院(不列顛哥倫比亞大學)的一名教授和醫師,專注於內分泌學和內科。他是加拿大皇家內科醫師及外科醫師學院的院士,並且是內分泌學會、高血壓國際學會、高血壓加拿大臨床實踐指導方針的活躍委員會成員,同時也是美國臨床內分泌學會的腦下垂體、性腺、腎上腺和神經內分泌資源中心的副主席。
Shmouni 博士是《內分泌與代謝科學》(Elsevier)的主編,並已撰寫或共同撰寫超過 100 篇有關神經內分泌、遺傳和代謝疾病的原創文章、評論和書籍章節。Shmouni 博士熱愛創業和早期風險投資工作;他共同創立了 FHS Capital,專注於早期創業諮詢和投資,並幫助早期創業者制定商業策略和籌集資金。